Novel commercially available genomic tests for prostate cancer: a roadmap to understanding their clinical impact

MeSH terms

• Access to Information
• Biomarkers, Tumor / genetics
• Cost-Benefit Analysis
• DNA Methylation
• DNA, Neoplasm
• Early Detection of Cancer*
• Gene Expression Regulation, Neoplastic
• Genome, Human
• Humans
• Male
• Prognosis
• Prostatic Neoplasms / diagnosis*
• Prostatic Neoplasms / genetics
• Prostatic Neoplasms / mortality
• Sentinel Surveillance